Latest Regulatory Milestones News

Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.

Jameson Resources has cleared a major environmental hurdle for its Crown Mountain steelmaking coal project, receiving the Section 27 Notice from British Columbia regulators and setting the stage for final application submission in October 2026.

Manhattan Gold Corporation has gained final regulatory approval and a CA$250,000 grant to kick off its maiden 4,000m RC drilling campaign at the Hook Lake Project in Nunavut, Canada.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.

Euro Manganese has cleared major regulatory hurdles for its Chvaletice Manganese Project, securing construction and land planning permits that significantly reduce project risk and pave the way for production in Europe’s only near-term high-purity manganese source.

Australian Silica Quartz Group (ASQ) has cleared a key regulatory hurdle with DMPE approval for the White Swan Kaolin Project’s Mining Development and Closure Proposal, paving the way for bulk sampling and offtake talks ahead of mining.

Aguia Resources has received official commercialisation approval for its Pampafos phosphate fertiliser project, enabling invoicing and marketing ahead of a targeted sales campaign designed to boost cash flow by mid-2026.

Bio-Gene Technology has raised A$3.21 million to complete critical safety studies for its novel insecticide Flavocide and ramp up production of its natural insecticide Qcide, advancing its path to commercialisation in multiple global markets.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

Aurum Resources has cleared a major regulatory hurdle with three environmental certificates granted for its 3.22Moz Boundiali Gold Project in Côte d’Ivoire, bringing the project closer to mining licence approval.

1414 Degrees Limited has responded to an ASX price query after its shares jumped from $0.056 to $0.097 in days, confirming no undisclosed information but highlighting progress in aerospace and energy projects.